Indian Melphalan Exporters: Complete Supplier Ranking with Market Share — 153 Manufacturers (2026) — TransData Nexus

Q: Who is the largest melphalan supplier from India?

EMCURE PHARMACEUTICALS LIMITED is the largest melphalan exporter from India with a 69.3% market share and export value of $8.8M.

Q: How many melphalan suppliers are there in India?

There are 153 active melphalan exporters in India, collectively shipping $12.8M worth of melphalan across 838 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top melphalan suppliers from India?

The top 5 melphalan suppliers from India — EMCURE PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, GLAND PHARMA LIMITED, EMCURE PHARMACEUTICALS LTD, INVEX HEALTH PRIVATE LIMITED — together control 86.9% of total melphalan export value from India.

Suresh Sormare

Melphalan

India Pharmaceutical Trade Intelligence

$12.8M153 Suppliers97 CountriesHS 30049049

ExportsIndia → RUSSIA23.4%India → UNITED KINGDOM21.3%

ImportsUNITED STATES → India$43.2K CANADA → India$38.8K

#1 Supplier: EMCURE PHARMACEUTICALS

Melphalan Suppliers from India (2026) — 153 Exporters, $12.8M Market | TransData Nexus | TransData Nexus

Who Exports Melphalan from India — 153 Suppliers Behind a $12.8M Market

India's melphalan export market is supplied by 153 active exporters who collectively shipped $12.8M across 838 shipments. EMCURE PHARMACEUTICALS LIMITED leads with a 69.3% market share, followed by SUN PHARMACEUTICAL INDUSTRIES LIMITED and GLAND PHARMA LIMITED. The top 5 suppliers together control 86.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Melphalan Suppliers & Exporters — 153 manufacturers, $12.8M export market, top destinations and formulations — Melphalan supplier data — 153 exporters · $12.8M market · 838 shipmentsTransData Nexus · Indian Customs Data

Top Melphalan Exporters from India — Ranked by Export Value

EMCURE PHARMACEUTICALS LIMITED is the leading melphalan exporter from India, holding a 69.3% share of the $12.8M market across 838 shipments from 153 exporters. The top 5 suppliers — EMCURE PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, GLAND PHARMA LIMITED, EMCURE PHARMACEUTICALS LTD, INVEX HEALTH PRIVATE LIMITED — collectively control 86.9% of total export value, indicating a highly concentrated market. Individual shares are: EMCURE PHARMACEUTICALS LIMITED (69.3%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (8.0%), GLAND PHARMA LIMITED (4.2%), EMCURE PHARMACEUTICALS LTD (3.5%), INVEX HEALTH PRIVATE LIMITED (1.8%).

Top Melphalan Exporters from India

Ranked by export value · 153 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Melphalan Exporters from India — Ranked by Export Value. 153 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Melphalan exporters

Certification and compliance status for top Melphalan suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Emcure Pharmaceuticals Limited	Warning Letter, March 201	Yes, 2023	Yes	Not verified	Received FDA warning letter in March 2019 for data integrity issues at Hinjawadi
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Not verified	Holds FDA approval and WHO-GMP certification; EU-GMP certified as of August 2019
Gland Pharma Limited	Approved	Yes	Yes	Not verified	FDA-approved; holds WHO-GMP and EU-GMP certifications.
Jodas Expoim Private Limited	Approved	Yes	Yes	Not verified	FDA-approved; holds WHO-GMP and EU-GMP certifications.
United Biotech Private Limited	Approved	Yes	Yes	Not verified	FDA-approved; holds WHO-GMP and EU-GMP certifications.
Celon Laboratories Private Limited	Approved	Yes	Yes	Not verified	FDA-approved; holds WHO-GMP and EU-GMP certifications.

TransData Nexus reviewed the regulatory standing of 6 leading Melphalan exporters from India. 5 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 6 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Melphalan sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous manufacturers specializing in Active Pharmaceutical Ingredients (APIs) and bulk drugs. For instance, SVK Laboratories, established in 2007, focuses on producing high-quality APIs and intermediates, adhering to Good Manufacturing Practices (GMP) and ISO 9001:2015 standards. Similarly, Vasudha Pharma Chem Ltd., located in Jeedimetla, Hyderabad, is known for its bulk drug and intermediate manufacturing capabilities. This concentration of bulk drug manufacturers makes Hyderabad a pivotal hub for sourcing raw materials essential for pharmaceutical formulations.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts a significant number of companies specializing in the production of finished dosage forms, including tablets, capsules, and injectables. For example, Alembic Pharmaceuticals, headquartered in Vadodara, manufactures and markets a wide range of pharmaceutical products, including APIs and formulations, with a presence in various therapeutic areas. Additionally, Schwitz Biotech in Ahmedabad engages in formulating, manufacturing, and exporting a diverse range of pharmaceutical formulations, adhering to FDA, WHO, GMP, and ISO 9002 quality standards. This specialization positions the Ahmedabad-Vadodara cluster as a key player in the production and export of pharmaceutical formulations.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Melphalan exporters from India

July 2024

M&A

EMCURE PHARMACEUTICALS LIMITED — Emcure expands Canadian presence with Mantra Pharma acquisition

Emcure Pharmaceuticals Limited acquired Mantra Pharma Inc., enhancing its footprint in the Canadian pharmaceutical market. IMPACT: This acquisition is expected to bolster Emcure's distribution channels, potentially increasing Melphalan exports to Canada, which currently accounts for 7.7% of total exports.

Impact: This acquisition is expected to bolster Emcure's distribution channels, potentially increasing Melphalan exports to Canada, which currently accounts for 7.7% of total exports.

March 2023

M&A

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Sun Pharmaceutical Industries Limited completed the acquisition of Concert Pharmaceuticals, a late-stage biotechnology company, for $576 million, aiming to strengthen its dermatology and autoimmune treatment portfolio. IMPACT: While this acquisition primarily enhances Sun Pharma's dermatology segment, it may indirectly support the company's oncology offerings, including Melphalan, through expanded research and development capabilities.

Impact: While this acquisition primarily enhances Sun Pharma's dermatology segment, it may indirectly support the company's oncology offerings, including Melphalan, through expanded research and development capabilities.

Common Questions — Melphalan Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which melphalan supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, EMCURE PHARMACEUTICALS LIMITED leads with 221 recorded shipments worth $8.8M. SUN PHARMACEUTICAL INDUSTRIES LIMITED (22 shipments) and GLAND PHARMA LIMITED (3 shipments) are also established high-volume exporters.

Q How many melphalan manufacturers are there in India?

India has 153 active melphalan exporters with a combined export market of $12.8M across 838 shipments to 97 countries. The top 5 suppliers hold 86.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for melphalan from India?

Average FOB unit price: $19.81 per unit, ranging from $0.01 to $141.34. Average shipment value: $15.2K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Melphalan

Melphalan

Who Exports Melphalan from India — 153 Suppliers Behind a $12.8M Market

Top Melphalan Exporters from India — Ranked by Export Value

Top Melphalan Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

EMCURE PHARMACEUTICALS LIMITED — Emcure expands Canadian presence with Mantra Pharma acquisition

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $576 million

Common Questions — Melphalan Suppliers from India

Q Which melphalan supplier from India is the most reliable for bulk orders?

Q How many melphalan manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for melphalan from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Analysis Methodology